Green tea intake and its effect on laboratory parameters and disease symptoms in hospitalised patients with Covid 19: a structured protocol for a randomized controlled trial
AbstractObjectivesThe current randomized controlled trial (RCT) will be conducted to assess the effect of green tea intake on disease symptoms and laboratory parameters including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and complete blood count (CBC) in patients with mild-to-moderate Covid-19 infection.Trial designRandomized, double-blinded, parallel (1:1 ratio) clinical trial exploratory studyParticipantsWe will recruit patients with COVID-19 infection admitted to Yasuj Shahid Jalil Hospital in Yasuj City, Kohgiluyeh and Boyer-Ahmad Province, Iran.Participants ’ inclusion criteria are as follows:I...
Source: Trials - August 3, 2021 Category: Research Source Type: clinical trials

Zinc and Green Tea Extract for Community Respiratory Viral Infections
Condition:   Respiratory Viral Infection Intervention:   Drug: zinc-green tea extract-ascorbic acid Sponsor:   University of Missouri-Columbia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2021 Category: Research Source Type: clinical trials

Clinical Study to Evaluate the Short Time Efficacy of AP Green Tea Extract Affer High Fat, High Carbohydrate Diet
Condition:   Blood Glucose, High Intervention:   Dietary Supplement: AP green tea extract Sponsor:   Amorepacific Corporation Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 20, 2021 Category: Research Source Type: clinical trials